Anna Kiialainen

4PUBLICATIONS
17CO-AUTHORS
BiofabricationInfant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Preventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 29, 2026
One-stage Assay Factor VIII Activity Reflects AAV-Derived Factor VIII-Enhanced Thrombin Activation and Predicts Phenotype.

|Dec 21, 2023
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial.

Steven W Pipe, Peter Collins, Christophe Dhalluin

|Aug 02, 2023
Clinical pharmacology of emicizumab for the treatment of hemophilia A.

Koichiro Yoneyama, Christophe Schmitt, Agnès Portron

|Jul 29, 2022
Effect of emicizumab prophylaxis on bone and joint health markers in people with haemophilia A without factor VIII inhibitors in the HAVEN 3 study.

Anna Kiialainen, Markus Niggli, Christine L Kempton

Pageof 1

Frequent Collaborators

1 joint publications

Christine L Kempton

1 joint publications

Koichiro Yoneyama

1 joint publications

Christophe Schmitt

1 joint publications

Naoki Kotani